PharmaLundensis
0,28 SEK
+6,15 %
Mindre end 1K følgere
PHAL
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
+6,15 %
+12,20 %
+21,05 %
-44,35 %
-26,98 %
-71,12 %
-61,27 %
-63,12 %
-91,59 %
PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.
Læs mereMarkedsværdi
16,56 mio. SEK
Aktieomsætning
24,9 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
6.2
2026
Årsrapport '25